CYductDX is developing genetic and clinical products for the identification, diagnosis and treatment of early breast disease as well as cancerous and pre-cancerous lesions within the milk ducts. The foundational premise of CyDuctDX as a breast care company is predicated on scientific research that has proven that changes in epithelia cells of the mammary ducts and subsequent breast ductal fluid composition are reflective of breast health and breast disease.
Copyright © 2024 American Medical Group LLC - All Rights Reserved.
Powered by GoDaddy